3 Must-Watch Issues For Drug Cos. In 2013's Final Stretch

3 Must-Watch Issues For Drug Cos. In 2013's Final Stretch

The rest of 2013 could reshape the pharmaceutical industry as regulators ponder new guidance on biosimilars and Congress weighs bills related to drug tracking and compounding pharmacies. Here are three pending regulatory and legislative moves for drugmakers ...read more

  • Tags: